Non-invasive Tests (NITs) in Liver Disease for APPs
Access expert-led MASH tools for diagnosis, staging, and management. Developed by GHAPP faculty specifically for APPs in community GI and li
Neoteric metabolic liver care incorporates non-invasive testing (NITs) in liver disease for APPs, allowing advanced practice providers to gauge the degree of liver fibrosis, refine their clinical approach, and circumvent invasive interventions. Given the alarming rise in metabolic liver ailments due to increasing incidences of obesity, type 2 diabetes, and metabolic syndrome, APPs are juggling multiple responsibilities including the crucial tasks of early recognition and systematic risk stratification. Validated tools such as fibrosis scores and elastography-based fibrosis scores are incorporated into NITs in liver disease for APPs, and have been designed to help clinicians target high-risk patients and decrease the burden of excessive referrals and interventions. The MASLD Community Network provides expert tutorials, digital tools, and interdisciplinary collaborations to APPs to enable them to efficiently apply NITs in the provision of routine and evidence-based care for patients with metabolic liver disorders.
NITs in liver disease for APPs offer a unique, evidence-based approach to metabolic liver disease and fibrosis risk evaluation and clinical decision support. By utilizing a combination of serum-based scores, imaging technologies, and algorithms, APPs can effectively identify high-risk individuals and direct them to the right care. With the resources and networking available through the MASLD Community Network, advanced practice providers can use the NITs for routine clinical practice and enhance the long-term health of patients with liver and metabolic issues.
